Benitec Biopharma's total assets for Q3 2024 were $15.00M, a decrease of -29.76% from the previous quarter. BNTC total liabilities were $3.50M for the fiscal quarter, a -40.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.